Skip to content

Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer

Randomized Controlled Trial of Progressive Resistance Exercise Training for Spinal Accessory Neurapraxia/ Neurectomy in Head and Neck Cancer Survivors

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00248235
Enrollment
64
Registered
2005-11-03
Start date
2005-09-30
Completion date
2009-01-31
Last updated
2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Neoplasms

Keywords

exercise, rehabilitation, head and neck neoplasms

Brief summary

The purpose of this study is to investigate the effect of a progressive therapeutic exercise program on specific physical and functional deficits in the neck and shoulder region occurring as a result of head and neck cancer treatment.

Detailed description

We will be conducting a randomized controlled trial to evaluate the effects of progressive resistance exercise training (PRET) on shoulder and neck dysfunction due to spinal accessory neurapraxia/ neurectomy in patients with head and neck cancer. Sixty-four head and neck cancer survivors will be randomly assigned to PRET or standard care. Participants assigned to the PRET group will exercise 3 times per week for 12 weeks. The goal of the exercise program will be to enhance scapular stability, and improve mobility and strength of the upper extremity. The resistance exercise program will be progressive in terms of the number of sets and repetitions performed, as well as amount lifted, depending on baseline strength levels and overall performance status. The primary outcomes for the study include pain and dysfunction, active and passive range of motion measures, strength and endurance testing, and quality of life. Nerve conduction testing and electromyography will be performed to assess/ monitor the status of the spinal accessory nerve and trapezius muscle function respectively.

Interventions

BEHAVIORALExercise

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx OR squamous cell carcinoma metastatic to the neck from unknown primary site; probable occult mucosal origin in the head and neck 2. Surgical treatment includes radical neck dissection, modified radical neck dissection and other variants of functional/selective neck dissection 3. Karnofsky Performance Status greater than or equal to 60% 4. No evidence of residual cancer in the neck and no distant (M0) metastasis 5. Participants must have completed their head and neck cancer treatment

Exclusion criteria

1. A history of shoulder or neck pathology unrelated to cancer treatment 2. Serious co-morbid medical illness or psychiatric illness

Design outcomes

Primary

MeasureTime frame
Pain and dysfunction (baseline, 12 weeks, 6 months, 12 months)baseline, 12 weeks, 6 months, 12 months
Active and passive range of motion (baseline, 12 weeks)baseline, 12 weeks
Muscular strength and endurance (baseline, 12 weeks)baseline, 12 weeks
Quality of life (baseline, 12 weeks, 6 months, 12 months)baseline, 12 weeks, 6 months, 12 months

Secondary

MeasureTime frame
Nerve conduction testing (baseline, 12 weeks as indicated)Baseline
Electromyography (baseline, 12 weeks as indicated)Baseline
Anxiety, depression and fatigue (baseline, 12 weeks, 6 months, 12 months)baseline, 12 weeks, 6 months, 12 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026